ZSZhong Shen

Zhong Shen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhong Shen has a total of 84 co-authors. Here are the top co-authors by number of shared publications:

  • Jun He

    Department of Colorectal Surgery, Hangzhou Third People’s Hospital, Hangzhou, Zhejiang, People’s Republic of China

    6 shared publications
  • Houdong Wang

    Hangzhou Third People’s Hospital

    4 shared publications
  • Xiufeng Zhang

    Department of Colorectal Surgery, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, P. R. China

    4 shared publications
  • Guohua Jiang

    School of Materials Science and Engineering, Zhejiang Sci–Tech University, Hangzhou, China

    3 shared publications
  • Hou-Dong Wang

    Department of Colorectal Surgery, Hangzhou Third People’s Hospital, Hangzhou, Zhejiang, People’s Republic of China

    3 shared publications
  • Rongchao He

    Zhejiang University School of Medicine, Hangzhou, Zhejiang, P. R. China

    3 shared publications

Latest Publications

  • Development of a Novel Anal-Fistula Plug Scaffold from Porcine Acellular Dermal Matrix/Hyaluronic Acid and Autologous Concentrated Growth Factor for Accelerating Fistula Healing

    by Houdong Wang, Yuzhe Zhang, Mengjie Zhong, Zhong Shen, Guohua Jiang

    In this study, a novel fistula plug stent (ACGF@G-PADM/HA) was designed to accelerate fistula healing. The scaffold uses a composite matrix of porcine acellular matrix and hyaluronic acid (PADM/HA) as a three-dimensional porous collagen framework, which functions as the "structural support", and autologous concentrated growth factor (ACGF) is a highly concentrated bioactive agent extracted from the patient's own blood, rich in a variety of growth factors, acting as "functional agents". The as-developed ACGF@G-PADM/HA plug scaffold showed excellent mechanical strength, overcoming defects such as the fast gelation of fibrin glue and the fixed shape of the anal plug, which allowed it to conform to the irregular and complicated structures of the fistula. Simultaneously, the ACGF was employed to induce angiogenesis (neovascularization) and fibroblast proliferation, thereby attaining a synergistic effect in promoting fistula healing. The novel filling material was capable of effectively preventing bacterial contamination, promoting the proliferation of granulation tissue, and accelerating wound healing. This facilitated tissue remodeling and ensured the integration of the fistula plug with the host tissue prior to its expulsion. The study anticipates that this new filling material can be utilized as a potential fistula plug scaffold for fistula treatment.

  • Open Access

    Autologous concentrated growth factors promote M2 macrophage polarization to accelerate wound healing after anal fistula surgery by activating the AKT/mTOR pathway

    by Xiufeng Zhang, Mengjie Zhong, Feifei Zhang, Miaoshan Lim, Jiazi Yu, Rongchao He, Jianming Qiu, Yuemin Yuan, Zhenfeng Lu, Houdong Wang, et al.

    Delayed healing of post-operative anal fistula wounds is driven by a hostile inflammatory microenvironment. While autologous concentrated growth factors (ACGF) show regenerative potential, the underlying immunomolecular mechanisms remain unclear. This study investigates if ACGF accelerates contaminated wound healing by modulating macrophage polarization via the AKT/mTOR pathway. In vitro, RAW264.7 macrophages were treated with ACGF to assess phenotypic switching and AKT/mTOR activation. The paracrine effects of ACGF-primed macrophages on fibroblasts were evaluated using a co-culture system with AKT-siRNA validation. In vivo, a rat fecal-contaminated wound model was established. Therapeutic efficacy, with or without the AKT inhibitor Triciribine, was assessed via laser speckle imaging, histology, and immunofluorescence. ACGF effectively reprogrammed macrophages from a pro-inflammatory M1 phenotype toward a reparative M2 phenotype, significantly upregulating CD206 and Arg-1 expression while activating AKT/mTOR signaling. Mechanistically, ACGF-primed macrophages significantly boosted RSF proliferation, migration, and collagen synthesis, effects that were substantially abrogated by AKT silencing. In vivo, ACGF treatment markedly accelerated wound closure, enhanced microvascular perfusion, and increased the density of CD31 + and Ki67 + cells. These regenerative benefits were accompanied by a significant shift toward M2 infiltration and a reduction in pro-inflammatory cytokines, all of which were reversed by pharmacological inhibition of AKT. ACGF promotes the healing of contaminated wounds by orchestrating an AKT/mTOR-dependent macrophage M2 polarization. This shift initiates a beneficial paracrine relay that enhances fibroblast activity and neoangiogenesis, effectively restoring the regenerative niche. Our findings establish ACGF as a potent immunomodulatory biomaterial and offer a promising therapeutic strategy for complex perianal wounds and chronic recalcitrant defects.

  • Danshen/Huanglian-loaded gelatin/Bletilla striata gum dressings accelerate wound healing in anal fistula by promoting angiogenesis through TGF-β/Smad pathway activation

    by Houdong Wang, Shuxian Shao, Wenjie Shen, Zhong Shen, Rongchao He

    Anal fistula (AF) is a common anorectal disease that significantly impairs patients’ quality of life. Dressings were frequently used for therapeutic wound healing. In this study, Danshen/Huanglian-loaded gelatin/Bletilla striata gum (DH-GB) dressings were prepared. The aim was to investigate its therapeutic effects and potential mechanism in AF. DH-GB, Danshen-loaded gelatin/Bletilla striata gum (D-GB), and GB dressings were prepared. AF models were constructed using wire surgery method, with dressing treatment for two weeks. Wound healing rate and blood flow were detected during this period. HE staining, MASSON staining, and immunohistochemistry for Angiopoietins-1 (Ang-1) expression were performed. In vitro, rat primary skin flbroblast cells (PRSFs) were randomized into Control, immersion solution of dressings (Danshen/Huanglian), Danshen/Huanglian + small interfering RNA-negative control (si-NC), and Danshen/Huanglian + siRNA targeting transforming growth factor-β (si-TGF-β) groups. Cell viability and cell proliferation were assessed by CCK8 and EdU assay. Additionally, both in vivo and in vitro, ELISA for VEGF levels and Western blot for TGF-β/Smad pathway-related expression were conducted. In AF rats, DH-GB treatment up-regulated wound healing rate, collagen deposition, and blood flow, increased VEGF, Ang-1, TGF-β, p-Smad2/Smad2, p-Smad3/Smad3, and p-Smad4/Smad4 expression, and improved pathological damage. Notably, DH-GB dressings exhibited enhanced efficacy in promoting wound healing compared to D-GB and GB dressings. Moreover, in rat PRSFs, Danshen/Huanglian promoted cell viability, cell proliferation, and enhanced VEGF, TGF-β, p-Smad2/Smad2, p-Smad3/Smad3, and p-Smad4/Smad4 expression, which were reversed by si-TGF-β. Our study revealed that DH-GB dressings promoted AF wound healing by stimulating angiogenesis through up-regulating TGF-β/Smad pathway, offering scientific foundation for its clinical application in AF.


  • Open Access

    Secondary Perianal Paget’s Disease Originating From Adenocarcinoma of the Anorectal Junction: A Case Report

    by Jun He, Rong-Chao He, Jian-Zhong Peng, Hou-Dong Wang, Tao Wang, Si-Jia Lu, Xiu-Feng Zhang, Zhong Shen

    Secondary extramammary Paget’s disease (EMPD), originating from the cutaneous dissemination of malignant cells, represents a rare subtype prone to misdiagnosis. This study presents a case of secondary perianal Paget’s disease (PPD) associated with adenocarcinoma at the anorectal junction. Preoperative full-thickness mapping biopsy was utilized for the assessment of lesion margins. The patient demonstrated favorable postoperative recovery following a multimodal therapeutic regimen.


  • Open Access

    Gut microbiota and perianal abscess and anal fistula: A bidirectional Mendelian randomization study

    by Rong-Chao He, Jun He, Hou-Dong Wang, Zhong Shen

    Perianal abscess and anal fistula are debilitating surgical conditions characterized by severe pain, persistent pus discharge, and prolonged recovery periods with high recurrence rates, collectively imposing profound burdens on patients’ quality of life, social functioning, and work productivity. Research has indicated potential distinction regarding the composition of gut microbiota in patients suffering from perianal abscess and anal fistula. The causal effect is yet unclear. The MiBioGen consortium was utilized to acquire data pertaining to gut microbiota, while the outcome data was provided by another project called the MRC Integrative Epidemiology Unit Open Genome-wide Association Studies (IEU Open GWAS) project. We performed bidirectional two-sample Mendelian randomization (MR) using inverse variance weighted (IVW) as the primary method, selected for its robustness to balanced pleiotropy when valid instrumental variables are used. Additionally, sensitivity analyses were conducted to examine the robustness of the results. Four gut microbiota taxa showed causal associations with perianal abscess risk: Eubacterium brachy group (OR = 1.41, P = .004), Ruminococcaceae UCG003 (OR = 0.61, P = .007), Erysipelatoclostridium (OR = 0.68, P = .009), and Butyrivibrio (OR = 0.81, P = .016). For anal fistula, 8 taxa were significant: Catenibacterium (OR = 1.22, P = .042) and Eubacterium ruminantium group (OR = 1.17, P = .013) increased risk, while Haemophilus (OR = 0.79, P = .005), Alloprevotella (OR = 0.78, P = .001), Ruminiclostridium5 (OR = 0.79, P = .019), Erysipelotrichaceae UCG003 (OR = 0.82, P = .034), Butyrivibrio (OR = 0.88, P = .006), and Escherichia-Shigella (OR = 0.82, P = .039) conferred protection. Furthermore, the findings from the sensitivity analyses demonstrate robust stability in these conclusions. Reverse MR analyses did not suggest reverse causality. This is the first MR investigation into the causal relationships between the onset of perianal infections and particular taxa of the gut microbiota. It enhances our comprehension of the correlation.


  • Open Access

    Identification of RNA binding protein genes associated with colorectal cancer by bioinformatics analysis

    by Rong-Chao He, Haibo Wang, Jun He, Hou-Dong Wang, Zhong Shen

    Colorectal cancer (CRC) is a prevalent malignant neoplasm on a global scale, with tumor heterogeneity driving therapeutic resistance and poor prognosis. RNA-binding proteins (RBPs), which are involved in regulating post-transcriptional processes, are becoming more recognized for their involvement in the advancement of cancer. This research conducted a thorough examination of the prognostic and functional significance of RBP-related gene sets (RBPGs) in CRC by utilizing transcriptomic data from the cancer genome atlas (TCGA). Differential expression analysis identified 406 RBPGs (268 upregulated, 138 downregulated) in CRC. Protein–protein interaction (PPI) network analysis revealed key modules involving 394 nodes, highlighting their functional interconnectivity. A prognostic model was constructed using 8 RBPGs (GTPBP4, KPNA2, CTNNA1, RRS1, SLFN11, CDKN2A, CHD3, TRAP1). This model effectively stratifies patients into 2 risk categories, each associated with differing survival outcomes. The model demonstrated robust predictive accuracy and was validated through subgroup analyses, receiver operating characteristic (ROC) curves, principal component analysis (PCA), and consistency index (C-index) curves. Integrating risk score, stage, and age, a nomogram was established to further enhance clinical applicability. Enrichment analysis linked high-risk groups to extracellular matrix remodeling, PI3K-Akt signaling, and immune evasion, while low-risk groups exhibited metabolic and immune activation pathways. Analysis of the tumor microenvironment (TME) indicated that high-risk patients exhibited elevated stromal and immune scores, alongside reduced tumor purity, which is associated with more aggressive phenotypic characteristics. Although tumor mutation burden (TMB) did not differ between risk groups, high TMB correlated with poorer survival. High-risk patients showed elevated tumor immune dysfunction and exclusion (TIDE) score and increased sensitivity to oxaliplatin, gemcitabine, and targeted therapies. In addition, we further experimentally verified the expression of the hub gene in the tissues of colorectal cancer patients. This study establishes RBP-based prognostic signatures, elucidates their mechanistic roles in CRC progression, and identifies potential therapeutic targets, providing a framework for personalized CRC management. Further validation in multicenter cohorts is warranted to translate findings into clinical practice.


  • Open Access

    S100A11 as an immune-related exosomal driver of colorectal cancer progression: a novel diagnostic biomarker

    by Haibo Wang, Rongchao He, Deng Liu, Jun He, Zhong Shen

    Background: Colorectal cancer (CRC) is a major cause of global cancer deaths, with increasing incidence among younger populations. Despite advancements in diagnostic and therapeutic strategies, early detection and effective treatment remain major challenges. Exosomes act as critical intercellular messengers, promoting cancer growth, immune escape, and chemotherapy resistance. This study aims to identify exosome-related biomarkers in CRC and elucidate the functional significance of S100A11 in tumor progression and immune regulation.Methods: We integrated multi-cohort transcriptomic data from TCGA and GEO databases and applied a machine learning triad (LASSO-SVM-Random Forest) to identify robust exosomal biomarkers for CRC. Functional enrichment analysis, immune infiltration evaluation, and molecular docking were performed, along with in vitro and in vivo experiments, including qPCR, Western blot, IHC, apoptosis assays, and xenograft models, were performed to validate the oncogenic and immunoregulatory role of S100A11.Results: A five-gene exosome-based diagnostic panel (S100A11, CA4, PDCD4, GSTM2, SORD) was established, demonstrating excellent predictive accuracy (AUC=0.965). S100A11 was identified as a master regulator of CRC proliferation, immune modulation, and chemoresistance. Knockdown of S100A11 significantly suppressed CRC cell proliferation, induced apoptosis, and restrained tumor development in a xenograft model. Moreover, S100A11 was associated with an immunosuppressive tumor microenvironment. Pharmacogenomic analysis revealed its potential as a therapeutic target, with high binding affinity to diallyl trisulfide, suggesting novel treatment avenues.Conclusion: S100A11 mechanistically promotes CRC progression by activating oncogenic signaling and reshaping the immune microenvironment, positioning it as a clinically relevant dual-function biomarker. The integration of bioinformatics, machine learning, and experimental validation underscores the potential of exosome-derived markers for immunotherapy and precision oncology. Future studies should focus on clinical validation and the development of exosome-based immune-targeted therapies for CRC management.


  • Open Access

    Netrin-1-CD146 and netrin-1-S100A9 are associated with early stage of lymph node metastasis in colorectal cancer

    by Jin-Ming Chen, Jun He, Jian-Ming Qiu, Guan-Gen Yang, Dong Wang, Zhong Shen

    The netrin-1/CD146 pathway regulates colorectal cancer (CRC) liver metastasis, angiogenesis, and vascular development. However, few investigations have yet examined the biological function of netrin-1/CD146 complex in CRC. In this work, we investigated the relationship between the netrin-1/CD146 axis and S100 proteins in sentinel lymph node, and revealed a possible new clue for vascular metastasis of CRC. The expression levels of netrin-1 and CD146 proteins in CRC, as well as S100A8 and S100A9 proteins in the sentinel lymph nodes were determined by immunohistochemistry. Using GEPIA and UALCAN, we analyzed netrin-1 and CD146 gene expression in CRC, their association with CRC stage, and their expression levels and prognosis in CRC patients. The expression level of netrin-1 in N1a+1b (CRC lymphatic metastasis groups, exculded N1c) was positively increased with N0 (p = 0.012). The level of netrin-1 protein was positively correlated with CD146 protein (p < 0.05). The level of S100A9 protein was positively correlated with CD146 protein (r = 0.492, p = 0.007). Moreover, netrin-1 expression was obviously correlated with S100A9 expression in the N1 stage (r = 0.867, p = 0.000). CD146 level was correlated with S100A9 level in the N2 stage (r = 0.731, p = 0.039). CD146 mRNA expression was higher in normal colorectal tissues than in CRC (p < 0.05). Netrin-1 and CD146 expression were not significantly associated with the tumor stages and prognosis of patients with CRC (p > 0.05). The netrin-1/CD146 and netrin-1/S100A9 axis in CRC tissues might related with early stage of lymph node metastasis, thus providing potential novel channels for blocking lymphatic metastasis and guiding biomarker discovery in CRC patients.


  • Open Access

    Hepatic IRE1α-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy

    by Yuexiao Tang, Tao Yao, Xin Tian, Xintong Xia, Xingxiao Huang, Zhewen Qin, Zhong Shen, Lin Zhao, Yaping Zhao, Bowen Diao, et al.

    Platinum-based chemotherapy drugs can lead to the development of anorexia, a detrimental effect on the overall health of cancer patients. However, managing chemotherapy-induced anorexia and subsequent weight loss remains challenging due to limited effective therapeutic strategies. Growth differentiation factor 15 (GDF15) has recently gained significant attention in the context of chemotherapy-induced anorexia. Here, we report that hepatic GDF15 plays a crucial role in regulating body weight in response to chemo drugs cisplatin and doxorubicin. Cisplatin and doxorubicin treatments induce hepatic Gdf15 expression and elevate circulating GDF15 levels, leading to hunger suppression and subsequent weight loss. Mechanistically, selective activation by chemotherapy of hepatic IRE1α-XBP1 pathway of the unfolded protein response (UPR) upregulates Gdf15 expression. Genetic and pharmacological inactivation of IRE1α is sufficient to ameliorate chemotherapy-induced anorexia and body weight loss. These results identify hepatic IRE1α as a molecular driver of GDF15-mediated anorexia and suggest that blocking IRE1α RNase activity offers a therapeutic strategy to alleviate the adverse anorexia effects in chemotherapy.